Lv4
500 积分 2022-07-20 加入
Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON
2个月前
已完结
Clinical implications of nintedanib pharmacokinetics in patients with pulmonary fibrosis
2个月前
已关闭
Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial
2个月前
已完结
Trajectories and Prognostic Significance of 6-Minute Walk Test Parameters in Fibrotic Interstitial Lung Disease
3个月前
已完结
PRO-C3 and PRO-C6 Fibrogenesis Biomarkers in Connective Tissue Disease-associated Interstitial Lung Disease: Results From the Phase IIb RECITAL Trial
5个月前
已关闭
Efficacy and safety of Qifang Feixian Granule in connective tissue disease-associated interstitial lung disease: a randomized, double-blind, placebo-controlled, multicenter study
5个月前
已关闭
Tofacitinib versus calcineurin inhibitors in anti-MDA5-positive dermatomyositis-associated interstitial lung disease: a randomized controlled trial
5个月前
已关闭
Lifetime spirometry patterns of obstruction and restriction, and their risk factors and outcomes: a prospective cohort study
10个月前
已完结
皖公网安备34019202002308
